Evidence map›Paper›PMID 29459424›Full record

ReviewBioscience reports2018

The role of adherens junction proteins in the regulation of insulin secretion.

Waruni C Dissanayake, Brie Sorrenson, Peter R Shepherd

Open access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Glycolytic activation of β-cell NaMolecular metabolism · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. CaFrontiers in endocrinology · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Is type 2 diabetes mellitus another intercellular junction-related disorder?Experimental biology and medicine (Maywood, N.J.) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Identification of PTP1B regulators fromIn silico pharmacology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Waruni C DissanayakeDepartment of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
Brie SorrensonDepartment of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
Peter R ShepherdDepartment of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand peter.shepherd@auckland.ac.nz.
Maurice Wilkins Centre · NZUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In healthy individuals, any rise in blood glucose levels is rapidly countered by the release of insulin from the β-cells of the pancreas which in turn promotes the uptake and storage of the glucose in peripheral tissues. The β-cells possess exquisite mechanisms regulating the secretion of insulin to ensure that the correct amount of insulin is released. These mechanisms involve tight control of the movement of insulin containing secretory vesicles within the β-cells, initially preventing most vesicles being able to move to the plasma membrane. Elevated glucose levels trigger an influx of Ca

Indexed as

Calcium SignalingAdherens JunctionsAnimalsGlucoseHumansInsulinInsulin-Secreting CellsGlucoseInsulinalpha-cateninbeta-cateninE-cadherininsulin secretionN-cadherin

Identifiers

PMID29459424
PMCPMC5861323
OpenAlexW2793516404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.